Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period

(Singapore, 1968-1997 cases followed-up until 1997)

Click on cancer site (ICD-10 code) for comparison
SiteICD-1010-year relative survival %15-year relative survival %
Period approach, Calendar periodCohort approach, Calendar periodPeriod approach, Calendar periodCohort approach, Calendar period
78-8283-8788-9293-9778-8283-8788-9293-9783-8788-9293-9783-8788-9293-97
C01-02Tongue23.021.033.131.924.922.427.521.623.628.635.427.322.824.4
C03-06Oral cavity18.329.932.233.319.128.223.620.828.832.932.324.214.822.9
C07-08Salivary gland47.474.556.465.838.254.467.158.784.557.755.157.044.862.6
C09Tonsil18.124.623.125.116.817.823.329.324.324.331.717.420.525.5
C11Nasopharynx26.630.240.144.420.624.528.437.222.133.739.217.917.326.1
C12-13Hypopharynx2.80.07.012.05.50.02.93.00.07.416.20.00.04.0
C15Oesophagus5.07.35.43.74.53.55.86.37.94.73.93.54.46.2
C16Stomach7.913.317.318.44.26.311.115.511.817.418.45.83.311.8
C18Colon29.138.746.647.126.029.433.739.936.345.845.827.724.633.4
C19-20Rectum20.226.034.040.914.917.222.731.424.736.240.417.614.822.6
C22Liver2.21.82.03.12.21.62.51.52.11.43.41.32.52.9
C23-24Gall bladder2.69.814.410.76.04.87.88.08.315.39.64.27.38.5
C25Pancreas5.87.24.14.86.25.43.46.28.93.45.35.66.23.6
C30-31Nose/Sinuses13.437.933.924.814.917.229.425.622.335.119.915.413.526.3
C32Larynx19.827.039.445.419.722.424.832.927.133.844.317.518.023.7
C33-34Lung4.15.35.35.83.23.85.24.74.84.65.33.52.54.9
C40-41Bone37.848.353.442.430.929.146.551.438.551.942.825.429.745.9
C44Other skin77.578.486.692.159.887.973.484.370.286.390.783.556.173.0
C47+C49Connective tissue33.054.143.047.637.940.737.046.151.142.245.338.137.737.3
C50Breast39.847.856.863.634.640.243.354.339.652.858.634.131.339.8
C53Cervix44.949.756.556.540.744.745.853.048.654.456.644.340.344.5
C54Corpus uteri57.466.874.379.647.245.561.375.563.270.579.547.543.257.2
C56Ovary43.156.863.460.739.543.151.257.151.363.160.140.636.551.3
C61Prostate19.726.424.241.520.222.018.529.729.416.624.219.714.910.7
C62Testis52.975.478.886.355.634.460.472.678.270.580.232.154.652.0
C64Kidney32.524.940.842.622.021.531.136.615.547.540.020.113.830.1
C67Urinary bladder39.441.258.459.231.227.342.553.229.263.159.324.624.945.3
C70-72Brain & nervous system26.619.722.622.811.117.226.121.719.120.821.916.79.924.0
C73Thyroid66.592.489.792.568.473.580.790.592.090.192.673.471.381.3
C81Hodgkin lymphoma30.340.535.268.522.232.040.731.433.036.459.229.520.039.8
C82-85+C96Non-Hodgkin lymphoma16.021.930.742.47.315.417.232.224.528.043.514.88.217.2
C90Multiple myeloma18.915.811.410.113.721.215.410.215.69.47.617.616.812.9
C91Lymphoid leukaemia12.112.39.319.51.912.512.111.45.19.617.49.31.012.6
C92-94Myeloid leukaemia0.73.44.812.01.31.72.06.03.73.59.11.20.01.7


Graphs:


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Singapore, 1993-1997 cases followed-up until 2001)
- Table5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Singapore, 1993-1997)
- Table6: Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1992 and 1993-1997 (Singapore)
- Table7b: Number of cases by cancer site and calendar period (Singapore Cancer Registry, 1968-1997)
- Table8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)
- Table9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)